54197-66-9: Cilostazol Related Compound A
It is an impurity present in Cilostazol. Cilostazol is a quinolinone derivative and antiplatelet agent have metabolites are cyclic AMP phosphodiesterase III inhibitors, inhibiting phosphodiesterase activity and suppressing cAMP degradation with a resultant increase in cAMP in platelets and blood vessels. cause inhibition of platelet aggregation and vasodilation. also reduces the symptoms of intermittent claudication as indicated by an increased walking distance.
Additional information on CAS 54197-66-9
VE006096
54197-66-9
C9H9NO2
163.17
Cilostazol
3, 4-Dihydro-6-hydroxy-2(1H)-quinolinone
N/A
Chi, Y.-W. (2008). Safety and efficacy of cilostazol in the management of intermittent claudication. Vascular Health and Risk Management, Volume 4, 1197–1203. https://doi.org/10.2147/vhrm.s3160
In-stock
